KARACHI: In a pharmaceutical innovation, SAAKH Group has announced an investment of over PKR 1 billion to develop Pakistan’s largest production facility for medicine pelletization and taste-masking in Karachi.
This cutting-edge initiative marks a significant expansion into a new sector, bringing advanced technologies to the local pharmaceutical landscape. The facility, the first of its kind in the country, represents a bold departure from traditional production models, positioning Pakistan at the forefront of specialized medicine manufacturing.
Scheduled to be fully operational by June 2026, the plant is not just a business venture but a statement of confidence in Pakistan’s economic stability and industrial potential.
Spokesperson for SAAKH Group commented, “We are proud to lead this transformation. Our investment is a testament to our faith in Pakistan’s capabilities and our commitment to delivering global-standard healthcare solutions. This initiative will significantly reduce Pakistan’s dependence on imported pharmaceutical technologies and raw materials, empowering the country to manufacture advanced formulations locally with greater efficiency and control.”
Copyright Business Recorder, 2025
Comments
Comments are closed for this article.